Sponsored Symposium 1:
Novel Therapies and Emerging Horizons in High-risk Neuroblastoma Management: Applying New Data to Practice in the US and EU
Date: Sunday, May 25, 2025
Time: 13:15 – 14:00
Hall: Plenary Hall
Join a panel of 4 globally recognized experts for a CME symposium centered on emerging research impacting the management of patients with high-risk neuroblastoma. Featuring panelists from the United States, France, and Germany, this program will compare and contrast American and European perspectives on the optimal application of new data to clinical practice. Attendees will also use iPads to answer polling questions and submit queries to the speakers to augment the conversations.
Provided by Haymarket Medical Education. Supported by an educational grant from Recordati Rare Diseases, Inc.
Speakers:
1. Welcome & Introductions, Thomas Cash, MD, MSc, Emory University School of Medicine, Atlanta, GA
2. Translational Research in Chemoimmunotherapy, Gudrun Schleiermacher, MD, PhD, Institut Curie, Paris, France
3. From the Bench to the Bedside: Clinical Implications of the Translational Findings – The US & EU Perspectives, Prof. Dr. Med. Holger Lode, Universitätsmedizin Greifswald, Greifswald, Germany &
Paul M Sondel, MD, PhD, Wisconsin Institutes for Medical Research, University of Wisconsin, Madison WI
• Q&A and Take-Home Messages, Thomas Cash, MD, MSc, Emory University School of Medicine, Atlanta, GA
Sponsored Symposium 2:
Mastering the molecules: Understanding polyamine mechanisms and their evolving role in neuroblastoma
Date: Monday, May 26, 2025
Time: 08:00 – 08:45
Hall: Hall C
Speakers:
Giselle Saulnier Sholler, MD, MSc, Division Chief, Pediatric Hematology/Oncology/BMT Penn State Hershey Children’s Hospital & Professor, Pediatrics and Pharmacology, Penn State University, College of Medicine & Chair, Beat Childhood Cancer Research Consortium
Michael D. Hogarty, MD, Division of Oncology, The Children’s Hospital of Philadelphia & Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania
Susan L. Cohn, MD, Professor and Director of Clinical Sciences, Department of Pediatrics, University of Chicago
Sponsored Symposium 3
Date: Tuesday, May 27, 2025
Time: 08:00 – 08:45
Hall: Hall C
Symposium title: FDA-Approved Anti-GD2 Cytotoxic Immunotherapy for High-Risk Neuroblastoma: Multi-center Efficacy and Safety Data Review
Speaker: Jacqueline M Kraveka, DO – Professor of Pediatrics & Pediatric Hematologist-Oncologist at the Medical University of South Carolina
Description: Join Y-mAbs Therapeutics, Inc. for a breakfast symposium featuring Jacqueline M Kraveka, DO, Professor of Pediatrics and Pediatric Hematologist-Oncologist at the Medical University of South Carolina. She will focus on an FDA-approved anti-GD2 cytotoxic immunotherapy for high-risk neuroblastoma, including reviewing the importance of Curie scores and sharing updated, multi-center efficacy and safety data.